Insulin-like growth factor-mediated muscle cell survival: Central roles for Akt and cyclin-dependent kinase inhibitor p21

Molecular and Cellular Biology

Volumn 20, Issue 23, 2000, Pages 8983-8995

  Lawlor, M A ^a   Rotwein, P ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; GROWTH FACTOR; MEMBRANE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INHIBITION; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, ANTISENSE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; MUSCLE, SKELETAL; NF-KAPPA B; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0034462138     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.23.8983-8995.2000     Document Type: Article

References (76)

1. The Bcl-2 protein family: Arbiters of cell survival
2. The role of PI 3-kinase in insulin action
3. Role of insulin-like growth factors in embryonic and postnatal growth
4. p21: Structure and functions associated with cyclin-CDK binding
5. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function
6. The role of the IGF-I receptor in apoptosis
7. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
8. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
9. Regulation of cell death protease caspase-9 by phosphorylation
10. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice
11. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways
12. Cellular survival: A play in three Akts
13. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
14. Role of phosphoinositide-3-OH kinase in Ras signaling
15. Regulation of neuronal survival by the serine-threonine protein kinase Akt
16. p21/p53, cellular growth control and genomic integrity
17. Cell cycle checkpoints: Preventing an identity crisis
18. Proliferation precedes differentiation in IGF-I-stimulated myogenesis
19. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line
20. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: Greater mitogenic actions of IGF-I delay differentiation
21. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II
22. PI3K: Downstream AKTion blocks apoptosis
23. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival
24. Inhibiting CDK inhibitors: New lessons from DNA tumor viruses
25. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos
26. Inhibition of myogenesis by multiple cyclin-Cdk complexes
27. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation
28. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
29. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB
30. The expanding role of cell cycle regulators
31. Induction of p21Waf1/Cipl by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells
32. Insulin-like growth factors and their binding proteins: Biological actions
33. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: Dominant negative p85 expression blocks differentiation of L6E9 muscle cells
34. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway
35. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells
36. Induction of NF-kappaB by the Akt/PKB kinase
37. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
38. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria
39. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
40. Akt is more than just a Bad kinase
41. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt
42. Direct control of the Forkhead transcription factor AFX by protein kinase B
43. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
44. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I
45. Dual control of muscle cell survival by distinct growth factor regulated signaling pathways
46. Molecular and cellular aspects of the insulin-like growth factor I receptor
47. Activation of insulin-like growth factor II expression during skeletal muscle regeneration in the rat: Correlation with myotube formation
48. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade
49. Ambient temperature regulation of apoptosis in brown adipose tissue. Erk1/2 promotes norepinephrine-dependent cell survival
50. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr)
51. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutal positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage
52. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I
53. The Bcl-2 family and cell death regulation
54. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase
55. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway
56. Wortmannin inhibits IGF-dependent differentiation in the mouse myogenic cell line C2
57. Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: Characterization of permissive and inducible C2 myoblasts
58. The cyclin-dependent kinase inhibitor p21/WAF1 is required for survival of differentiating neuroblastoma cells
59. Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures
60. Type-1 insulin-like growth factor receptor overexpression produced dual effects on myoblast proliferation and differentiation
61. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
62. Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation
63. Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II
64. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts
65. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation
66. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/Re1A subunit
67. Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation
68. Growth, differentiation and survival: Multiple physiological functions for insulin-like growth factors
69. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts
70. Negative regulation of the forkhead transcription factor FKHR by Akt
71. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation
72. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation
73. Switching signals on or off by receptor dimerization
74. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
75. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
76. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step